Margaretha Rudas

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Martin Filipits, Margaretha Rudas, R. Jakesz et al. · Clinical Cancer Research · 2011 · 728 citations · Full text

Medicine, Cancer Biology, Oncology +17

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Michael Gnant, Martin Filipits, Richard Greil et al. · Annals of Oncology · 2013 · 399 citations · Full text

Medicine, Oncology, Breast Oncology +13

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

Peter Dubsky, Jan C. Brase, R. Jakesz et al. · British Journal of Cancer · 2013 · 349 citations · Full text

Medicine, Endocrinology, Oncology +17

Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density

Christopher C. Riedl, Nikolaus Luft, Clemens Bernhart et al. · Journal of Clinical Oncology · 2015 · 303 citations · Full text

Medicine, Oncology, Radiology +17

TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.

Daniela Kandioler-Eckersberger, Christian Ludwig, Margaretha Rudas et al. · PubMed · 2000 · 286 citations

Medicine, Oncology, Pharmacology +14